Mason & Associates, LLC / NVSN
Mason & Associates, LLC’s Novartis AG Position
Does Mason & Associates, LLC own Novartis AG (NVSN)? Not currently — the last reported position was 20.0K shares worth $2M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$2M
Q1 2024
Shares
20.0K
% of Portfolio
+1.47%
Quarters Held
1
position exited
Position History NVSN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2024 | 20.0K | $2M | +1.47% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mason & Associates, LLC’s full portfolio or all institutional holders of NVSN.